Revised forecast
Fiscal year ending December 2026 · Six months and full yearPrevious forecast published 13 February 2026The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
The revision reflects the weaker yen, capital investment demand, particularly in the LNG sector, demand driven by aircraft manufacturers' production expansion plans, growing demand for dialysis services, particularly in Europe, costs to prepare for future risks and one-off operating profit of approximately ¥2 billion related to business restructuring in prior years.
| Item | Details |
|---|---|
| Net Sales | ¥233,500 million → ¥247,700 million（+6.1%） |
| Operating profit | ¥16,500 million → ¥19,700 million（+19.4%） |
| Profit attributable to owners of the parent | ¥13,000 million → ¥15,800 million（+21.5%） |
| Net income per share | 199.19 yen and sen → 241.93 yen and sen |
| Fiscal Period Covered | Fiscal year ending December 2026 |
| Period Covered | Six months and full year |
| Publication date of previous forecast | 13 February 2026 |
| Previous-period results | Revenue: ¥215,642 million; operating profit: ¥15,331 million; profit before tax: ¥17,255 million; profit for the period attributable to owners of the parent: ¥13,652 million; basic earnings per share: ¥206.22 |
| Reason for the revision | The revision reflects the weaker yen, capital investment demand, particularly in the LNG sector, demand driven by aircraft manufacturers' production expansion plans, growing demand for dialysis services, particularly in Europe, costs to prepare for future risks and one-off operating profit of approximately ¥2 billion related to business restructuring in prior years. |
| Dividend forecast revision | Both the interim and year-end dividend forecasts were increased. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The interim results exceeded the forecasts due to the foreign-exchange impact of the yen's depreciation, control of selling, general and administrative expenses, the postponement of expense recognition and an increase in foreign-exchange gains. For the full year, the forecasts were revised upward against a backdrop of capital investment demand in the LNG sector, aircraft manufacturers' production expansion plans, demand for dialysis treatment in overseas markets and the weaker yen. The revised forecasts also incorporate costs to prepare for future risks and one-off operating profit of approximately ¥2 billion related to business restructuring in prior years.